This suggests potential utility as a stratification biomarker for identifying sporadic PD patients with increased LRRK2 activity, but it remains to be determined if increased mtDNA damage in sporadic PBMCs is indeed LRRK2 dependent. Here, LRRK2 is linked to Parkinson disease.